NCT07110454View on ClinicalTrials.gov

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

Not yet recruitingOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
EpilepsyEpilepsy (Treatment Refractory)
Interventions
DEVICE

Previous receipt of the Minder System (implantable continuous electroencephalographic (EEG) monitoring (iCEM) system)

The Minder System consists of an implanted device containing an electrode lead and telemetry unit. The electrode lead contains four electrodes that are placed under the patient's scalp to record electrical activity (EEGs) from both sides of the brain. The electrode lead is connected to the telemetry until that continuously transmits these signals to the external Minder devices to remotely show EEGs for clinician review.

All Listed Sponsors
lead

Epiminder America, Inc.

INDUSTRY

NCT07110454 - Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up | Biotech Hunter | Biotech Hunter